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Abstract 
Epidemiologic studies indicate blood glucose management in the hospitalized patient 
population is not adequate; with approximately 30% of patients reporting values >180mg/dl.  
Patients with increased blood glucose levels pose a higher mortality risk as well as increased 
risks for dehydration, hypotension, renal injury, decreased wound healing, immunosuppression, 
and an overall increase in hospital length of stay (AACE, 2015).  This project aims to improve 
inpatient management of blood glucose levels by facilitating MD-RN communication through a 
reduction in the current reportable blood glucose level.  This project took place on a 17 bed adult 
medical-surgical unit at a large academic hospital in the San Francisco Bay Area. Data collection 
demonstrated hypoglycemia rates of 1.85%, normoglycemia rates of 56.5%, and hyperglycemia 
rates of 41.6%, which lead to the implementation of a new addition to the subcutaneous insulin 
order-set.  Education regarding this new order has been provided to the medical-surgical staff 
nurses in addition to the conduction of a formal presentation to the Nurse Educator Forum and 
Diabetes Champion Committee for hospital wide dissemination.   
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Improving Management of Inpatient Blood Glucose 
Clinical Leadership Theme 
This project aims to highlight the role of the Clinical Nurse Leader (CNL) as a Team 
Manager by designing, implementing, and evaluating bedside point of care provided on a general 
care medical-surgical unit at a large academic teaching hospital in the San Francisco Bay Area.  
This project will focus on the CNL curricular element of Clinical Outcomes Management 
through the utilization of an existing database to analyze and aggregate care outcomes for the 
microsystem to drive changes in nursing practice and improve patient outcomes by improving 
inpatient blood glucose management.   
Statement of the Problem 
The American Association of Clinical Endocrinologists (2015) state that epidemiologic 
studies indicate blood glucose management in the hospitalized patient population is not adequate; 
with approximately 30% of patients reporting values >180mg/dl.  Patients with increased blood 
glucose levels pose a higher mortality risk as well as increased risks for dehydration, 
hypotension, renal injury, decreased wound healing, immunosuppression, and an overall increase 
in hospital length of stay (LOS).   
Nurses on the general care medical-surgical unit care for a variety of patients with 
multifaceted medical needs, including those with Complicated Diabetes Mellitus.  Data gathered 
from bedside glucometers has been aggregated into percentage values to better identify monthly 
trends of hypoglycemia, normoglycemia, and hyperglycemia within the microsystem.  The 
analyzed data identified average hypoglycemia rates of 1.85%, normoglycemia rates of 56.5%, 
and hyperglycemia rates of 41.6%.  These numbers fall well below the institutional target of 
maintaining normoglycemia rates of 85% on the general care units.     
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In an attempt to combat the issue of mismanaged dysglycemia, this project will focus on 
lowering the current standard Provider notification threshold glucose level as well as enhancing 
the current subcutaneous insulin order-set with the addition of a new nursing communication 
order. This new standard of reporting will require nurses to notify Providers of trends in  
hyperglycemia that may otherwise go untreated.   
Literature Review 
For patients admitted to the medical-surgical unit, how does lowering the current 
reportable glucose level to >300mg/dL compare to the current standard of only reporting levels 
>400mg/dL affect the total number of recorded hyperglycemic (>180mg/dL) episodes within the 
next 6 months.   
In an attempt to answer this question and thoroughly investigate the importance of 
inpatient blood glucose management and its influence on diabetes related health outcomes, an 
electronic review of the literatures was conducted utilizing the databases CINAHL, Medline, and 
Google Scholar for articles published between the years 2000 and 2015 with no limits applied to 
study type.  The initial key term searched was “inpatient blood glucose management” which 
yielded over 32,000 articles.  The key term search was then further refined by using the terms 
“inpatient blood glucose”, “inpatient hyperglycemia”, and “inpatient glycemic target” which 
yielded a total of 69 related articles that were relevant to the stated question.  Of those 69 
articles, 6 have been chosen as primary supporting evidence for this project.   
The literary consensus amongst the experts is that management of inpatient blood glucose 
is a serious matter which has a significant impact on patient care outcomes if left unaddressed.  
Diabetes mellitus ranks as one of the most costly chronic conditions with an estimated associated 
care cost of $40 billion per year (Patel & Doughty ,2008).  Along with this severe financial 
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burden to the US healthcare system, inpatient dysglycemia has also been associated with 
increases in mortality, hospital associated complications, readmission rates, and hospital length 
of stay(Schmeltz, 2010).    
In response to this, the American Association of Clinical Endocrinologists (2015) have 
published a consensus statement highlighting recommendations for the treatment of inpatient 
dysglycemia. The AACE endorses the need to identify inpatient elevations in glucose, utilization 
of a multidisciplinary approach to inpatient diabetes management, implementation of structured 
protocols glucose control, and the creation of education programs for hospital staff charged with 
caring for dysglycemic patients (Schmeltz, 2010).  The AACE also outlined their recommended 
inpatient prandial glucose targets to be below 140mg/dL and all random glucose levels to be 
below 180mg/dL (Moghissi et al., 2009).  Oftentimes, this is difficult to achieve considering the 
majority of inpatients with dysglycemia have been admitted to the hospital with a more pressing 
primary problem, resulting in glycemic management falling to the wayside.   
The best way to achieve proper inpatient glucose management is through the use of basal-
bolus insulin dosing and maintaining recommended best practice techniques when collecting 
blood glucose samples (Louie, Tang, Sutton, et al., 2000).  To accomplish this, it is important for 
multidisciplinary collaboration to occur between physicians, nurses, and pharmacists to promote 
education and increase awareness of the need for, and desire to change current cultural practices 
(Moghissi, 2010).  
Rationale 
To better assess the current state of blood glucose management on the medical-surgical 
unit, an analysis of daily data collected by bedside point of care glucometers was performed.  
This data is readily available to all hospital employees via the diabetes team care site found 
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within the hospital’s intranet.  The collected data is aggregated at the end of each month, broken 
down by department, and categorized as either hypoglycemic (<70mg/dL), normoglycemia 
(71mg/dL-180mg/dL), or hyperglycemic (>181mg/dL).  The aggregated data for the medical-
surgical unit for the months of April 2015 – June 2015 indicate mean hypoglycemia rates of 
1.85%, normoglycemia rates of 56.5%, and hyperglycemia rates of 41.6% (Appendix G).   
To investigate barriers that may have contributed to these results, a 5 question survey was 
distributed to the nurses on the medical-surgical unit.  Survey results yielded an 80% response 
rate that indicated a lack of understanding regarding proper management of inpatient blood 
glucose, uncertainty of when to notify the physician of poor glucose management due to 
confusion surrounding current insulin order-set (Appendix E).   Results of data analysis and staff 
survey were discussed with the Diabetes Nurse Education Specialist and resident 
Endocrinologist to demonstrate a need for action to improve diabetes related patient outcomes.  
The multidisciplinary team validated the need for the project’s implementation and encouraged 
the utilization of a cause and effect (Appendix B) analysis and SWOT analysis (Appendix C) to 
identify any potential barriers and strengths prior to moving forward with the proposed 
interventions.   
Cost Analysis 
Estimated time spent towards project implementation will be approximately 200 hours  
that includes research, intervention development and implementation, stakeholder meetings, staff 
education, data analysis, and generating reports.  Working on this project as a graduate student 
will result in zero monetary compensation needed from organization with an associated 
compensatory cost of $0.  As a result, the institution will greatly benefit from the implementation 
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of this project based on the potential cost savings associated with improved inpatient glycemic 
management.    
To aid in the business case for this project, a literary review produced evidence to 
illustrate the financial incentives associated with proper inpatient glucose management.  A study 
performed at a large teaching hospital in Virginia found a correlation in the frequency of 
catheter-associated urinary tract infections (CAUTI), central line infections (CLABSI), ventilator 
associated pneumonia (VAP), and surgical site infections (SSI) (Fogel & Baker, 2013) with 
decreased blood glucose levels.  For some financial perspective, Scott (2009) estimates costs 
associated with various healthcare associated infections to be: $754 per CAUTI, $10,443 per 
SSI, $22,939 per CLABSI, and $25,072 per VAP.     
Similar conclusions have also been met by the American Association of Clinical 
Endocrinologists and American Diabetes Association.  A 2009 article summarized various 
studies like the Portland Diabetic Project that found an achievement in target blood glucose 
levels reduced the prevalence of sternal wound infections by 66% which resulted in a savings of 
approximately $4,638 per patient (Moghissi, et al, 2009).  The same article also cited another 
study conducted at a large tertiary care trauma center which found that a reduction in the 
organization’s monthly mean blood glucose level by 26mg/dl resulted in a substantial decreased 
in length of stay (LOS) with an associated cost savings of over two million dollars per year 
(Moghissi, et al, 2009).   
In light of study results such as these, it is important to consider that effective October 1, 
2008 the Centers for Medicare and Medicaid (CMS) will no longer reimburse for certain 
Hospital Acquired Conditions, including manifestations of poor glycemic control (CMS, 2014).  
This pertains to specific conditions such as diabetic ketoacidosis (DKA), nonketotic 
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hyperosmolar coma, hypoglycemic coma, secondary diabetes with ketoacidosis, and secondary 
diabetes with hyperosmolarity.    
While monetary gain is always a driving force in quality improvement, the primary aim 
of this project is to improve patient outcomes.  As nurses, the primary concern is always for the 
health and wellbeing of the patients.  If the organization can make financial gains from a nurse 
driven practice change, that is a bonus that will rank second to improving patient outcomes.   
Project Overview 
This project took place at a large teaching hospital in the San Francisco Bay Area.  The 
institution is comprised of a multitude of unique microsystems that service an extremely diverse 
patient population.  The microsystem of focus for this project is a 17 bed general care medical-
surgical unit dedicated to the care of adult patients ages 18-100+ who present with a variety of 
medical needs.  Common diagnosis observed within the microsystem include Diabetes Mellitus, 
Cystic Fibrosis Related Diabetes (CFRD), Adult Cystic Fibrosis, transplant rejection, chronic 
renal failure, and liver failure.  The majority of patients are admitted directly from the 
Emergency Department or transferred from sister units with a higher level of care.   
The unit is comprised of a core staff of 26 registered nurses, 6 nursing assistants, 4 unit 
secretaries, and the patient care management team who work closely with their multidisciplinary 
colleagues to provide holistic patient centered care.  The majority of nurses on the medical-
surgical unit are recent nursing graduates with <5 years of experience, hailing from a variety of 
specialty backgrounds with varying levels of nursing expertise.   
Based on literary evidence citing the importance of reducing inpatient blood glucose 
levels, the aim of this project is to improve blood glucose management in patients admitted to the 
medical-surgical unit by decreasing the reportable blood glucose threshold from >400mg/dL to 
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>300mg/dL in addition to enhancing the current subcutaneous insulin order-set with the addition 
of a nursing communication order that will instruct nurses to “notify MD of 3 blood sugar levels 
>250mg/dL in 24 hours.” 
Methodology 
Utilizing the PDSA (Plan-Do-Study-Act) model, the improvement process began by 
gathering 3 months’ worth (April 2015 – June 2015) of baseline blood glucose data collected by 
bedside point of care glucometers on the medical-surgical unit to assess current rates of 
hypoglycemia (<70mg/dL), normoglycemia (71mg/dL-180mg/dL), and hyperglycemia 
(>180mg/dL).  Concurrently, a survey was distributed to the staff nurses and informal interviews 
were conducted in an attempt to identify barriers in treating inpatient dysglycemia (Appendix D).    
Data gathered from the survey and interview questions promoted a change to the current 
default insulin order-set that was proposed for implementation.  The current standard of practice 
on the medical-surgical unit is for the nurse to check a patient’s blood glucose level within 1 
hour prior to eating a meal, or as ordered by the Provider.  Based on the blood glucose level, the 
nurse will open the Electronic Medication Administration Record (EMAR) and determine the 
type and dose of subcutaneous insulin to administer based on the ordered insulin sliding scale.  
Located within the sliding scale insulin administration order is a comment that states to give the 
ordered insulin based on the patient’s blood glucose level and to notify the MD of a blood 
glucose level >400mg/dL.      
This order to “notify MD if blood glucose >400mg/dL” has led to confusion amongst the 
nurses who believe the Provider should be notified at a lower threshold (Appendix E) but fail to 
do so because of this communication order.  This failure to notify the Provider of blood glucose 
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levels that are not adequately maintained has resulted in overall poor management of inpatient 
glucose on the medical-surgical unit.   
In order to improve the management of inpatient blood glucose on the medical-surgical 
unit, the proposed change to decrease the reportable blood glucose threshold from >400mg/dL to 
>300mg/dL was discussed with the Diabetes Nurse Education Specialist, MD’s on the Inpatient 
Endocrinology Service, and the nursing lead Diabetes Champion Committee members.  Debate 
between the nurses and the Endocrinologists regarding this threshold reduction has yet to reach a 
consensus.  However, all were in agreement with the proposed addition of a nursing 
communication order which specifies to “notify MD of 3 blood sugar levels >250mg/dL in 24 
hours.”   
The next step in the change process was to submit an EPIC (EHR) ticket with the 
proposed order-set change.  Collaboration with the Senior Clinical Nursing Informatics 
Specialist saw the implementation of the proposed change July 20th following approval of 
clinical experts.  A mid-project assessment occurred August 1st to evaluate the status of the 
project and identify any barriers they may prevent a timely completion. The project will 
conclude at the end of the calendar year with the collection of 3 months’ worth of data (post 
change implementation) collected by bedside point of care glucometers on the medical-surgical 
unit to compare new rates of hypoglycemia, normoglycemia, and hyperglycemia.   
This process is expected to improve inpatient blood glucose management through the 
achievement of normoglycemia rates of 65% or higher for 3 months, reducing hyperglycemia 
rates to 35% or lower for 3 months, and maintaining the current rates of hypoglycemia for 3 
months.  Accomplishing these target goals will lead to an improvement in overall patient 
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outcomes, decrease the average length of stay, and reduce costs associated with poor glucose 
management.  
Change Theory 
The change theory utilized throughout this project is Lewin’s Change Management 
Model Theory.  Lewin’s Model successfully accomplishes change through the completion of 
three phases: unfreezing, moving, and refreezing (Kritsonis, 2005).  These phases focus on 
strengthening contributing factors that will support the proposed change as well as restricting 
factors that may interfere with the proposed change.     
During the unfreezing phase, surveys were sent out and informal interviews were 
conducted with the medical-surgical staff nurses in an effort to better understand their perceived 
barriers to adequate inpatient diabetes management.  Based on results of the survey and 
interviews, many of the nurses articulated that their current practice is woefully inadequate when 
it comes to managing blood glucose levels.  Almost all expressed desire for more education 
regarding diabetes management to result in the best possible outcomes for their patients.  This 
response indicates that the staff nurses successfully accomplished the unfreezing phase by 
demonstrating readiness for change and willingness to improve the current standards of practice.     
The moving phase of Lewin’s Change Model commenced when the proposed change is 
implemented and education was provided to the staff nurses regarding the new change in 
practice.  Following successfully implementation, the refreezing phase will begin with the 
incorporation of the change into daily workflow.  For this phase to be successful, follow-up 
education will be provided to the staff nurses along with data visualization to demonstrate either 
the success or failure of the change.  If the post intervention data indicates a statistically 
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significant improvement, the staff nurses will be more likely to “refreeze” their behavior to 
ensure a permanent practice change 
Timeline 
The project began May 2015 with the collection and analysis of monthly data from April 
2015 – June 2015.  In the beginning of June 2015 surveys and informal interviews were 
conducted with the medical-surgical staff nurses.  By the end of June, responses from surveys 
and interviews were analyzed and the proposed interventions were based on the results.  July saw 
the project shift focus to facilitate collaboration with the nursing informaticist to make the 
requested changes in the EHR.  A mid-project check-in occurred August 1st to assess the current 
status of the project and identify any potential barriers to implementation.  The go-live date for 
the inclusion of the “notify MD” order to the EHR insulin order-set ensued July 20th with 
dissemination of information to the hospital wide Nurse Educator forum occurring on July 28th.   
The project will conclude December 1st, 2015 with final data collection and analysis taken from 
the months following the interventional implementation (September – November).  Refer to 
Appendix A for an outline of the project timeline.     
Nursing Relevance 
The successful implementation of this project has numerous implications for the nursing 
profession.  Improving the management of inpatient blood glucose will result in an elevation in 
the overall quality of care provided within the hospital with the added bonus of optimizing 
patient healthcare outcomes.   
While there are currently no studies available to provide official recommendations for 
insulin reporting thresholds, this project will hope to add to the literature by demonstrating better 
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inpatient glucose management as a result of increased MD awareness of dysglycemia resultant of 
increased communication with the nursing staff.            
Expected Results 
Currently there is a disconcerting laissez faire cultural attitude on the medical-surgical 
unit amongst the nursing staff and physicians when it comes to managing dysglycemia.  The 
proposed changes have been formulated to promote a sense of urgency in reporting and 
managing inpatient hyperglycemia.  Following implementation of the interventions, a gradual 
increase in the rates of normoglycemia to 65%, are expected to reflect within the monthly 
glucose data as a result of this new and heightened awareness.    
Sustainability 
The sustainability of a process improvement project is critical to its longevity and in the 
end, will determine the effect of change on the desired patient population.  In order to maximize 
the sustainability of this project and reinforce the invested time and effort, staff education 
concerning the EHR changes and data awareness will continue to be a priority.   
While disseminating information regarding the new “notify MD” order, supplemental 
education will also be provided to all staff nurses demonstrating how to quickly and easily 
review a graph of glucose trends through the utilization of a preexisting flow-sheet in the EPIC 
EHR which easily identifies when a patient has had more than 3 blood glucose levels 
>250mg/dL in 24 hours.  In addition to educational reinforcement, data trends will be added to 
monthly staff newsletters as well as prominently displayed on the unit visibility wall.  This 
display of monthly glucose trends aim to promote data literacy as well as visually translating 
data correlations between nursing action and patient outcomes.   
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Evaluation 
At the time of this report, only one of two proposed changes has achieved “go-live” 
status.  The addition of the order stating “Notify MD of 3 blood sugar levels >250mg/dL in 24 
hours” has been successfully included to the default subcutaneous insulin order-set and now 
appears on the EPIC EHR RN order summary page.   Education regarding this new order has 
been presented to the Nurse Educator forum who will in turn diffuse the information to the 
nurses on their respective units.  Post-change data collection will begin September 1st in order to 
give the nurses time to receive education regarding new order implementation and develop an 
efficient utilization process.   
Three months of post implementation data will be collected for the months of September, 
October, and November.  Data will be aggregated on December 1st and analyzed for trends in 
glucose management.  It is expected that the data review process will demonstrate a decrease in 
hyperglycemia rates which will in turn reveal an increase in the percentage of normoglycemia 
rates.   
In addition to the above mentioned “notify MD” order, this project proposed a change in 
the reportable prandial blood glucose from that of >460mg/dL to a more reasonable >250mg/dL.  
This proposed order change has been a topic of contention between the Diabetes Nurse 
Champion Committee and the MD Inpatient Endocrinology team.  The Diabetes Nurse 
Specialists believe 460mg/dL is an unacceptably high number and as a result may be effecting 
patient care when less experienced nurses fail to report hyperglycemia as a result of this 
physician order.  On the  other hand, the endocrinologists feel that a reduction in the reportable 
threshold will lead to an increased number of pages to the covering intern/resident and as a 
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result, inhibit the development of a healthy nurse-physician relationship.  This topic is currently 
under review and will aim to seek a resolution by the end of August.   
Conclusion 
Carly Fiorina (2004), president of Hewlett-Packard once said “the goal is to transform 
data into information, and information into insight.” Improving the management of inpatient 
blood glucose is only one small part of an extremely complex plan of care for the diabetic 
patient. By utilizing data systems currently in place to illustrate and drive the need for process 
improvement initiatives, nurses can feel empowered to advocate for changes that will improve 
the care they provide and positively impact their patient’s health outcomes.   
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Appendix B 
 
 
 
 
 
 
 
 
 
  
 
Poor Inpatient Blood Glucose 
Management 
People 
Processes 
Equipment 
Management 
Environment 
RN knowledge deficit of 
inpatient glucose management 
 
Patient compliance  
 
5:1 patient/nurse ratio  
 
Time constraints  
Stressful hospital environment 
Availability of bedside glucometers  
Default insulin order-set 
No unit based daily tracking of 
trending glucose levels 
Unit based culture of care 
 
Insulin order-sets stating to notify 
provider if glucose >400 
Timing of glucose checks and 
insulin administration  
 
IMPROVING INPATIENT BLOOD GLUCOSE     20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strengths 
 
 High levels of RN staff engagement  
 Small unit with few nurses  
 RNs dedicated to improving patient outcomes  
 Minimal costs associated with proposed change  
     Weaknesses  
 
 Busy unit 5:1 nurse/patient ratio  
 Multiple insulin administration orders placed in 
electronic health record (basal, bolus, carb 
correction, etc…) 
 Utilization of float/travel nurses  
 Frequent turnover of interns, residents, and 
attending physicians 
 Achieving sustainable results  
Opportunities  
 
 Improve communication between nurses and 
providers 
 Empower nurses to advocate for better inpatient 
glucose control  
 Improve staff knowledge of diabetes and 
inpatient glucose management  
 Utilize unit diabetic champion as an information 
resource  
   Threats 
 
 Achieve adequate Provider buy-in for proposed 
intervention  
 Fail to achieve closed-loop communication 
between Providers and staff nurses  
 Potential unforeseen interferences with daily 
workflow  
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SWOT Analysis 
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Appendix D 
NURSE SURVEY 
INPATIENT BLOOD GLUCOSE MANAGEMENT 
 
1. At what blood glucose level do you think microvascular damage occurs?  
 227mg/dl 
 181 mg/dl 
 126 mg/dl 
 305mg/dl 
 
2. At what blood glucose level do you typically notify the MD/Provider  
 185mg/dl 
 275mg/dl 
 400mg/dl 
 Whatever number the order tells me too  
 Other (please specify) ____________________ 
 
3. At what blood glucose level do you THINK we should notify the MD/Provider  
 301 mg/dl 
 251mg/dl 
 181 mg/dl 
 Other (please specify) ____________________ 
 
4. What are some barriers you face when treating hyperglycemia?  
 Confusion regarding insulin types and their acting time 
 Presence of MD/Provider order to notify if >400mg/dl 
 Timing of insulin administration 
 Other (please specify) _______________________ 
 
5. Are there any specific topics you would like further education on regarding inpatient 
diabetes management?  
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Appendix E 
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Appendix F  
2015 Inpatient Blood Glucose Trends  
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Appendix G 
2015 Three Month Average Inpatient Blood Glucose Trend  
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Appendix H 
Subcutaneous Insulin Order Set 
 
 
 
 
 
 
 
